ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

EMD Serono Research & Development Institute, Inc. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
breast-cancergastric-cancernsclcovarian-cancerpancreatic-ductal-adenocarcinoma
advanced solid tumors, ly6e expression, topoisomerase i inhibitor (top1i), nsclc, breast cancer, gastric cancer, head and neck squamous cell carcinoma, ovarian cancer, pancreatic ductal adenocarcinoma, systemic antibody-drug conjugate therapy (adc) therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 876209
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.